CLINICAL SUPPLY MANAGEMENT ARTICLES
The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Patient enrollment can vary widely due to a number of variables, introducing risk into the supply chain. Here's why its critical to be aware of these risks and how best to mitigate them within trials.
-
The pharmaceutical industry is full of acronyms. Gain insight into the evolution of the acronyms, the technology and the terminology, specifically for RTSM (Randomization and Trial Supply Management).
-
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Explore the logistical risk management factors to consider when deciding to switch to direct-to-patient shipments in the EU.
-
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.